Researchers have discovered that SGLT2 inhibitors, a class of drugs originally developed to treat diabetes and now widely ...

Pharmacist-run telephone clinics at one Peterborough practice were linked to a 42% decrease in GP heart failure workload.

McGill researchers have developed a new way to study why the same heart failure treatment can help some patients recover while others continue to get worse.

You can follow a treatment plan and take medications as a doctor prescribes to manage congestive heart failure. Eat a heart-healthy diet and stay physically active to slow heart failure progression.

A new review finds that combining SGLT2 inhibitors with GLP-1 receptor agonists in heart failure is mechanistically plausible ...

Panelists discuss their excitement about the evolution of heart failure as a distinct specialty with multiple effective therapeutic options, the convergence of previously siloed medical disciplines ...

There were 928 patients with CHF (i.e., International Classification of Diseases, 9th Revision, Clinical Modification codes 428, 402.01, 402.11,402.91, and 404) admitted to our institution between ...

A widely used heart failure medication called sacubitril/valsartan was associated with a lower risk of heart damage compared to placebo among high-risk cancer patients being treated with anthracycline ...

An estimated 32 million people globally have heart failure with reduced ejection fraction, a condition where the lower left chamber of the heart does a poor job of pumping blood to the rest of the ...

Heart failure disproportionately affects the black community, with research showing significantly higher rates compared to other populations. While various factors contribute to this disparity, ...

Share on Pinterest Could personalized text “nudges” help to reduce medication nonadherence? Image credit: Maskot/Getty Images A new study suggests that receiving personalized SMS text “nudges” about ...

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among high-risk cancer patients undergoing chemotherapy treatment using anthracyclines ...